Home>>Signaling Pathways>> Membrane Transporter/Ion Channel>> TRP Channel>>HC-030031

HC-030031

Catalog No.GC15947

HC-030031 is a selective inhibitor of transient receptor potential ankyrin subfamily member 1 (TRPA1). HC-030031 blocks calcium influx in cells, with IC50 values of 4.9±0.1 and 7.5±0.2μM for calcium influx induced by cinnamaldehyde and allyl isothiocyanate (AITC), respectively.

Products are for research use only. Not for human use. We do not sell to patients.

HC-030031 Chemical Structure

Cas No.: 349085-38-7

Size Price Stock Qty
10mM (in 1mL DMSO)
$15.00
In stock
1mg
$10.00
In stock
5mg
$20.00
In stock
10mg
$32.00
In stock
25mg
$56.00
In stock
50mg
$84.00
In stock
100mg
$126.00
In stock
200mg
$175.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 5 publications

Description of HC-030031

HC-030031 is a selective inhibitor of transient receptor potential ankyrin subfamily member 1 (TRPA1). HC-030031 blocks calcium influx in cells, with IC50 values of 4.9±0.1 and 7.5±0.2μM for calcium influx induced by cinnamaldehyde and allyl isothiocyanate (AITC), respectively[1-2].

In HEK293 cells expressing TRPA1, HC-030031 (10μM) rapidly and reversibly blocks inward and outward currents induced by AITC or formalin, but has no effect on currents mediated by TRPV1, TRPV3, TRPV4, hERG, or NaV1.2 channels[2]. Blocking TRPA1 with HC-030031 (10μM) inhibited apoptosis of HEK293 cells, reduced the levels of IL-1β, IL-6, TNF-α and INF-γ, and reduced the levels of cleaved-cas3, cleaved-PARP and iNOS[3].

HC-030031 at a dose of 100mg/kg reduced the pain response behavior of mice in the AITC-induced pain model. Oral HC-030031 (100mg/kg) significantly reversed mechanical hypersensitivity in a more chronic, fully Fredrick-adjuvant (CFA) -induced model of inflammatory pain and a spinal nerve ligation model of neuropathic pain[1]. In formalin-induced pain behavior in rats, HC-030031 (30, 100, and 300mg/kg) reduced the number of flinching events in a dose-dependent manner, and at the 300mg/kg dose, the number of flinching events was reduced to a level similar to that of saline injection[2].

References:
[1] Eid S R, Crown E D, Moore E L, et al. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory-and neuropathy-induced mechanical hypersensitivity[J]. Molecular pain, 2008, 4: 1744-8069-4-48.
[2] McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, Zhao M, Hayward NJ, Chong JA, Julius D, Moran MM, Fanger CM. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13525-30.
[3] Yuan J, Liang X, Zhou W, Feng J, Wang Z, Shen S, Guan X, Zhao L, Deng F. TRPA1 promotes cisplatin-induced nephrotoxicity through inflammation mediated by the MAPK/NF-κB signaling pathway. Ann Transl Med. 2021 Oct;9(20):1578.

Protocol of HC-030031

Cell experiment [1]:

Cell lines

HEK-293 cell line stably expressing TRPA1

Preparation Method

HC-030031 at concentrations ranging from 0.3 to 60μM was incubated with cells for 10min, and then cinnamaldehyde or AITC was added, and calcium influx assays were performed using a fluorescent imaging microplate reader.

Reaction Conditions

0.3-60μM, 10min

Applications

HC-030031 dose-dependently blocked cinnamaldehyde- and AITC-induced calcium influx with IC50 values of 4.9 and 7.5μM, respectively.

Animal experiment [1]:

Animal models

Spinal cord nerve ligation injury rat mode

Preparation Method

After confirming the successful induction of mechanical hypersensitivity, the rats were divided into average groups and given 100mg/kg or 300mg/kg HC-030031 or 20mg/kg naproxen, respectively. The mechanical threshold was then reassessed 1 hour after dosing.

Dosage form

100 or 300mg/kg, 1h, p.o.

Applications

HC-030031 significantly attenuated inflammation and neuropathy-induced mechanical hypersensitivity 1 hour after administration.

References:
[1] Eid S R, Crown E D, Moore E L, et al. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory-and neuropathy-induced mechanical hypersensitivity[J]. Molecular pain, 2008, 4: 1744-8069-4-48.

Chemical Properties of HC-030031

Cas No. 349085-38-7 SDF
Chemical Name 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide
Canonical SMILES CC(C)C1=CC=C(C=C1)NC(=O)CN2C=NC3=C2C(=O)N(C(=O)N3C)C
Formula C18H21N5O3 M.Wt 355.39
Solubility ≥ 16.4mg/mL in DMSO Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of HC-030031

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.8138 mL 14.0691 mL 28.1381 mL
5 mM 0.5628 mL 2.8138 mL 5.6276 mL
10 mM 0.2814 mL 1.4069 mL 2.8138 mL
  • Molarity Calculator

  • Dilution Calculator

  • Molecular Weight Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution) of HC-030031

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

Reviews

Review for HC-030031

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for HC-030031

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.